Assignee
KASHIV BIOSCIENCES LLC
US·21 granted patents·41 pending applications·45 citations·filing 2013–2025
Top patents by PatentIndex Score
62 records- 0197US10898430B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV BIOSCIENCES LLC·Filed 2020·Granted Jan 26, 2021·5 cites·12 claims
- 0297US10898431B2Programmable pharmaceutical compositions for chrono drug releaseKASHIV BIOSCIENCES LLC·Filed 2020·Granted Jan 26, 2021·8 cites·11 claims
- 0397US10869839B2Extended release compositions comprising trihexyphenidylKASHIV BIOSCIENCES LLC·Filed 2020·Granted Dec 22, 2020·5 cites·11 claims
- 0497US10849846B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV BIOSCIENCES LLC·Filed 2020·Granted Dec 1, 2020·6 cites·20 claims
- 0595US10744083B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV BIOSCIENCES LLC·Filed 2019·Granted Aug 18, 2020·6 cites·13 claims
- 0692US12139510B2Process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2024·Granted Nov 12, 2024·3 cites·21 claims
- 0791US10744093B2Extended release compositions comprising pyridostigmineKASHIV BIOSCIENCES LLC·Filed 2020·Granted Aug 18, 2020·2 cites·18 claims
- 0891US10588863B2Extended release compositions comprising pyridostigmineKASHIV BIOSCIENCES LLC·Filed 2019·Granted Mar 17, 2020·2 cites·19 claims
- 0986US12378282B2Process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2024·Granted Aug 5, 2025·0 cites·8 claims
- 1086US11229606B2Extended release compositions comprising pyridostigmineKASHIV BIOSCIENCES LLC·Filed 2019·Granted Jan 25, 2022·1 cites·18 claims
- 1186US10987311B2Extended release compositions comprising pyridostigmineKASHIV BIOSCIENCES LLC·Filed 2019·Granted Apr 27, 2021·2 cites·20 claims
- 1285US10857098B2Gastroretentive dosage forms for sustained drug deliveryKASHIV BIOSCIENCES LLC·Filed 2020·Granted Dec 8, 2020·1 cites·14 claims
- 1385US10406234B2Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage formsKASHIV BIOSCIENCES LLC·Filed 2015·Granted Sep 10, 2019·2 cites·17 claims
- 1483US12435106B2Process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2024·Granted Oct 7, 2025·0 cites·29 claims
- 1583US2025353877A1Process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2025·Application pending·0 cites
- 1679US10500282B2Supersaturated stabilized nanoparticles for poorly soluble drugsKASHIV BIOSCIENCES LLC·Filed 2013·Granted Dec 10, 2019·2 cites·9 claims
- 1776US2024287159A1Process for preparation of stable protein solutionKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 1873US12440534B2Stable ready to dilute composition of carfilzomibKASHIV BIOSCIENCES LLC·Filed 2024·Granted Oct 14, 2025·0 cites·16 claims
- 1972US2025099873A1Process of affinity chromatographyKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2070US2025043027A1Formulation of highly concentrated pharmacologically active antibodyKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2170US2024317799A1Process for purification of proteinKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2270US2023340080A1Process for preparation of stable protein solutionKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 2370US2024343758A1Process for purification of proteinKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2469US2023167153A1An improved process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 2568US2026014226A1Stable ready to dilute composition of carfilzomibKASHIV BIOSCIENCES LLC·Filed 2025·Application pending·0 cites
- 2667US2024352061A1Process for separation and quantification of non-ionic surfactantKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2765US2025296014A1An improved process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2025·Application pending·0 cites
- 2864US2025059230A1An improved method for separation of low molecular weight proteinsKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 2964US2019343957A1Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage FormsKASHIV BIOSCIENCES LLC·Filed 2019·Application pending·0 cites
- 3063US2025244334A1An improved method for separating and detecting of free or residual polyethylene glycol in pegylated protein mixtureKASHIV BIOSCIENCES LLC·Filed 2023·Application pending·0 cites
- 3160US2024343776A1Process for purification of fusion proteinKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 3260US2022267473A1Formulation of highly concentrated pharmacologically active antibodyKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 3358US2023166201A1An improved process of affinity chromatographyKASHIV BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 3458US2023166200A1An improved process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 3558US2024254160A1Separation of pre-peak and post-peak in fusion protein sample by using size exclusion high performance liquid chromatographyKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 3657US2024400612A1An improved process for purification of fusion proteinKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 3756US10744131B2Abuse-resistant drug formulationsKASHIV BIOSCIENCES LLC·Filed 2014·Granted Aug 18, 2020·0 cites·20 claims
- 3855US12352759B2Assay method of antibodyKASHIV BIOSCIENCES LLC·Filed 2024·Granted Jul 8, 2025·0 cites·19 claims
- 3954US2024156907A1Novel formulation of fusion proteinKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 4053US2025296015A1An improved process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2025·Application pending·0 cites
- 4152US2025236640A1Separation of pre-peak in fusion protein sample by using size exclusion high performance liquid chromatographyKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 4252US2022241184A1Gastroretentive dosage forms of levodopa and carbidopaKASHIV BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 4352US2024287207A1Process for improving polypeptide expression in mammalian cell cultureKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 4452US2022260521A1A process for separation and quantitation of proteins using capillary electrophoresisKASHIV BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 4551US2023348530A1An improved process of storing and preparing the proteinKASHIV BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 4648US2023158099A1Stable ready to dilute formulations of carfilzomibKASHIV BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 4747US2021145846A1High-concentration fulvestrant compositionsKASHIV BIOSCIENCES LLC·Filed 2018·Application pending·0 cites
- 4846US2025136931A1An improved cell culture process for production of proteinKASHIV BIOSCIENCES LLC·Filed 2023·Application pending·0 cites
- 4945US2024069025A1Method for size based evaluation of pancreatic protein mixtureKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 5045US2023303621A1Improved process for the separation and analysis of pancreatic enzymesKASHIV BIOSCIENCES LLC·Filed 2023·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →